Loading…
EnPlusOne Biosciences provides a flexible enzymatic platform for RNA synthesis, enabling unrestricted scale and access to novel RNA modifications. Their technology overcomes current manufacturing limitations by supporting high-purity long RNA and a broader design space beyond the 20 modifications accessible through chemical synthesis.
AI named EnPlusOne Biosciences in January 2026.